"Global PARP Inhibitor Biomarkers Market Overview:
Global PARP Inhibitor Biomarkers Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global PARP Inhibitor Biomarkers Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of PARP Inhibitor Biomarkers involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the PARP Inhibitor Biomarkers Market:
The PARP Inhibitor Biomarkers Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for PARP Inhibitor Biomarkers Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study PARP Inhibitor Biomarkers Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, PARP Inhibitor Biomarkers market has been segmented into:
Product Type (Kits and Assays
By Application, PARP Inhibitor Biomarkers market has been segmented into:
BRCA 1 & 2 Testing
HRD Testing
HRR Testing and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The PARP Inhibitor Biomarkers market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the PARP Inhibitor Biomarkers market.
Top Key Players Covered in PARP Inhibitor Biomarkers market are:
Myriad Geneticsinc.
F. Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratoriesinc.
BPS Bioscienceinc. Antibodies Inc.
Networks LLC
Beckman Coulterinc.
Euro Diagnostica AB
F. Hoffmann-La Roche Ltd.
Qiagen NV
Siemens Healthcare GmbH
Bio Rad Laboratories Inc.
Exagen Inc.
Genway Biotechinc.
Microdrop LLC (imaware)
Svar Life Science AB and Thermo Fisher Scientific Inc.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: PARP Inhibitor Biomarkers Market by Type
4.1 PARP Inhibitor Biomarkers Market Snapshot and Growth Engine
4.2 PARP Inhibitor Biomarkers Market Overview
4.3 Product Type (Kits and Assays
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Product Type (Kits and Assays: Geographic Segmentation Analysis
Chapter 5: PARP Inhibitor Biomarkers Market by Application
5.1 PARP Inhibitor Biomarkers Market Snapshot and Growth Engine
5.2 PARP Inhibitor Biomarkers Market Overview
5.3 BRCA 1 & 2 Testing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 BRCA 1 & 2 Testing: Geographic Segmentation Analysis
5.4 HRD Testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 HRD Testing: Geographic Segmentation Analysis
5.5 HRR Testing and Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 HRR Testing and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 PARP Inhibitor Biomarkers Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MYRIAD GENETICSINC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 F. HOFFMANN-LA ROCHE AG
6.4 INVITAE CORPORATION
6.5 NEOGENOMICS LABORATORIESINC.
6.6 BPS BIOSCIENCEINC. ANTIBODIES INC.
6.7 NETWORKS LLC
6.8 BECKMAN COULTERINC.
6.9 EURO DIAGNOSTICA AB
6.10 F. HOFFMANN-LA ROCHE LTD.
6.11 QIAGEN NV
6.12 SIEMENS HEALTHCARE GMBH
6.13 BIO RAD LABORATORIES INC.
6.14 EXAGEN INC.
6.15 GENWAY BIOTECHINC.
6.16 MICRODROP LLC (IMAWARE)
6.17 SVAR LIFE SCIENCE AB AND THERMO FISHER SCIENTIFIC INC.
Chapter 7: Global PARP Inhibitor Biomarkers Market By Region
7.1 Overview
7.2. North America PARP Inhibitor Biomarkers Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Product Type (Kits and Assays
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 BRCA 1 & 2 Testing
7.2.5.2 HRD Testing
7.2.5.3 HRR Testing and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe PARP Inhibitor Biomarkers Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Product Type (Kits and Assays
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 BRCA 1 & 2 Testing
7.3.5.2 HRD Testing
7.3.5.3 HRR Testing and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe PARP Inhibitor Biomarkers Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Product Type (Kits and Assays
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 BRCA 1 & 2 Testing
7.4.5.2 HRD Testing
7.4.5.3 HRR Testing and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific PARP Inhibitor Biomarkers Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Product Type (Kits and Assays
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 BRCA 1 & 2 Testing
7.5.5.2 HRD Testing
7.5.5.3 HRR Testing and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa PARP Inhibitor Biomarkers Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Product Type (Kits and Assays
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 BRCA 1 & 2 Testing
7.6.5.2 HRD Testing
7.6.5.3 HRR Testing and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America PARP Inhibitor Biomarkers Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Product Type (Kits and Assays
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 BRCA 1 & 2 Testing
7.7.5.2 HRD Testing
7.7.5.3 HRR Testing and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
PARP Inhibitor Biomarkers Scope:
|
Report Data
|
PARP Inhibitor Biomarkers Market
|
|
PARP Inhibitor Biomarkers Market Size in 2025
|
USD XX million
|
|
PARP Inhibitor Biomarkers CAGR 2025 - 2032
|
XX%
|
|
PARP Inhibitor Biomarkers Base Year
|
2024
|
|
PARP Inhibitor Biomarkers Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Myriad Geneticsinc., F. Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratoriesinc., BPS Bioscienceinc. Antibodies Inc., Networks LLC, Beckman Coulterinc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Exagen Inc., Genway Biotechinc., Microdrop LLC (imaware), Svar Life Science AB and Thermo Fisher Scientific Inc..
|
|
Key Segments
|
By Type
Product Type (Kits and Assays
By Applications
BRCA 1 & 2 Testing
HRD Testing
HRR Testing and Others
|
